openPR Logo
Press release

Parkinson's Disease Drugs Market 2020 Global Top Key Players, Emerging Size, Growth Factor, Share- Novartis, Orion Pharma Ltd, ACADIA Pharmaceuticals Inc.

03-27-2020 02:22 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

Parkinson's Disease Drugs Market 2020 Global Top Key Players,

The global Parkinson's disease drugs market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled "Parkinson's Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%.

Increasing usage approvals are contributing to the growth of the global Parkinson's disease drugs market. The Food and Drug Administration recently cleared two new drugs for the treatment of Parkinson's disease. The drug approvals for Rytary and Duopa will emerge as breakthroughs in the healthcare industry.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/parkinson-s-disease-drugs-market-100655

Leading Players operating in the Parkinson's Disease Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Pfizer, Inc.
o F. Hoffmann-La Roche Ltd
o Merck & Co., Inc.
o Novartis
o Orion Pharma Ltd
o UCB S.A
o Teva Pharmaceutical Industries Ltd.
o Vertical Pharmaceuticals, LLC
o ACADIA Pharmaceuticals Inc.
o Impax Laboratories, Inc.
o H. Lundbeck A/S.

Detailed Table of Content:

o Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
o Executive Summary
o Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Market Trends
o Key Insights
o Prevalence of Parkinson's Disease - For Key Countreis, 2018
o Regulatory Scenario - For Key Countries
o Patent Snapshot
o New Product Launch
o Pipeline Analysis
o Key Industry Developments - Mergers, Acquisitions and Partnerships
o Global Parkinson's Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
o Key Findings / Summary
o Market Analysis, Insights and Forecast - By Drug Class
? Decarboxylase Inhibitors
? Dopamine Agonists
? Monoamine Oxidase Type B (MAO-B) Inhibitors
? Catechol-O-Methyltransferase (COMT) Inhibitors
? Others
o Market Analysis, Insights and Forecast - By Route of Administration
? Oral
? Injection
? Transdermal
o Market Analysis, Insights and Forecast - By Distribution Channel
? Hospital Pharmacy
? Retail Pharmacy
? Online Stores
o Market Analysis, Insights and Forecast - By Region
? North America
? Europe
? Asia Pacific
? Latin America
? Middle East & Africa
o North America Parkinson's Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
o Key Findings / Summary
o Market Analysis - By Drug Class
? Decarboxylase Inhibitors
? Dopamine Agonists
? Monoamine Oxidase Type B (MAO-B) Inhibitors
? Catechol-O-Methyltransferase (COMT) Inhibitors
? Others
o Market Analysis - By Route of Administration
? Oral
? Injection
? Transdermal
o Market Analysis - By Distribution Channel
? Hospital Pharmacy
? Retail Pharmacy
? Online Stores
o Market Analysis - By Country
? U.S.
? Canada

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/parkinson-s-disease-drugs-market-100655

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson's Disease Drugs Market 2020 Global Top Key Players, Emerging Size, Growth Factor, Share- Novartis, Orion Pharma Ltd, ACADIA Pharmaceuticals Inc. here

News-ID: 1988141 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% CAGR During the Forecast Period
Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% …
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period. Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacement
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Forecast Period.
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca …
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023. Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032." Request a Free Sample
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Companies- Nike, Supreme, Stussy, BAPE
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan …
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period. Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear is
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- L'Oréal S.A.( France), Unilever Plc (U.K.), Coty Inc. (U.S.)
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- …
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period. Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost the

All 5 Releases


More Releases for Parkinson

Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025? The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period? The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $1.43 billion
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%. Increasing Geriatric Population Driving Demand: The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,